Bought
Maintained
Sold
Other funds holding LLY
LBP AM's LLY Position: Q3 2026 in Review
LBP AM reduced its Eli Lilly (LLY) stake by 55% in Q3 2026, selling an estimated $108M and leaving 73,384 shares worth $84.9M. The position accounts for 0.76% of the portfolio, ranked #19.
LBP AM first reported a position in LLY in Q4 2022 and has held it in 16 quarters since. The position peaked at $241M in Q4 2025. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- LBP AM held 73,384 shares of Eli Lilly worth $84.9M as of Q3 2026.
- LBP AM sold 91,514 Eli Lilly shares in Q3 2026, an estimated $108M.
- Eli Lilly made up 0.76% of LBP AM's portfolio in Q3 2026, its #19 holding.
- LBP AM first reported a position in Eli Lilly in Q4 2022 and has held it in 16 quarters since.
- LBP AM's Eli Lilly position peaked at $241M in Q4 2025.
- 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on LBP AM's 13F filing for Q3 2026, filed 6 Nov 2026.